Abstract
Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 488-495 |
| Number of pages | 8 |
| Journal | Clinical Obstetrics and Gynecology |
| Volume | 61 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 1 2018 |
Fingerprint
Keywords
- endometrial cancer
- gynecologic cancer
- hormone therapy
- menopause
- ovarian cancer
ASJC Scopus subject areas
- Obstetrics and Gynecology
Cite this
Menopausal Hormone Therapy in Gynecologic Cancer Survivors : A Review of the Evidence and Practice Recommendations. / Kapoor, Ekta; Benrubi, Daniel; Faubion, Stephanie S.
In: Clinical Obstetrics and Gynecology, Vol. 61, No. 3, 01.09.2018, p. 488-495.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Menopausal Hormone Therapy in Gynecologic Cancer Survivors
T2 - A Review of the Evidence and Practice Recommendations
AU - Kapoor, Ekta
AU - Benrubi, Daniel
AU - Faubion, Stephanie S.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.
AB - Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.
KW - endometrial cancer
KW - gynecologic cancer
KW - hormone therapy
KW - menopause
KW - ovarian cancer
UR - http://www.scopus.com/inward/record.url?scp=85050979382&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050979382&partnerID=8YFLogxK
U2 - 10.1097/GRF.0000000000000381
DO - 10.1097/GRF.0000000000000381
M3 - Review article
C2 - 29762148
AN - SCOPUS:85050979382
VL - 61
SP - 488
EP - 495
JO - Clinical Obstetrics and Gynecology
JF - Clinical Obstetrics and Gynecology
SN - 0009-9201
IS - 3
ER -